Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XLRN - Acceleron Pharma Inc

Previous close
178.75
0   0%

Share volume: 0
Last Updated: Fri 19 Nov 2021 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing : -4.32%

PREVIOUS CLOSE
CHG
CHG%
$178.75
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 18%
Dept financing 12%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$178.75
P/E Ratio 
0.00
DAY RANGE
$178.75 - $178.75
EPS 
-$4.20
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
61.156 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Habib Dable
Region: US
Website: www.acceleronpharma.com
Employees: 312
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Recent news